MX2022002753A - Preparacion humeda de fuentes de radioterapia. - Google Patents

Preparacion humeda de fuentes de radioterapia.

Info

Publication number
MX2022002753A
MX2022002753A MX2022002753A MX2022002753A MX2022002753A MX 2022002753 A MX2022002753 A MX 2022002753A MX 2022002753 A MX2022002753 A MX 2022002753A MX 2022002753 A MX2022002753 A MX 2022002753A MX 2022002753 A MX2022002753 A MX 2022002753A
Authority
MX
Mexico
Prior art keywords
radium
solution
atoms
radionuclides
thorium
Prior art date
Application number
MX2022002753A
Other languages
English (en)
Inventor
Itzhak Kelson
Michael Schmidt
Original Assignee
Alpha Tau Medical Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Alpha Tau Medical Ltd filed Critical Alpha Tau Medical Ltd
Publication of MX2022002753A publication Critical patent/MX2022002753A/es

Links

Classifications

    • G—PHYSICS
    • G21—NUCLEAR PHYSICS; NUCLEAR ENGINEERING
    • G21G—CONVERSION OF CHEMICAL ELEMENTS; RADIOACTIVE SOURCES
    • G21G4/00—Radioactive sources
    • G21G4/04—Radioactive sources other than neutron sources
    • G21G4/10—Radioactive sources other than neutron sources with radium emanation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N5/00—Radiation therapy
    • A61N5/10—X-ray therapy; Gamma-ray therapy; Particle-irradiation therapy
    • A61N5/1001—X-ray therapy; Gamma-ray therapy; Particle-irradiation therapy using radiation sources introduced into or applied onto the body; brachytherapy
    • A61N5/1014—Intracavitary radiation therapy
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/025—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus inorganic Tc complexes or compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/12—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by a special physical form, e.g. emulsion, microcapsules, liposomes, characterized by a special physical form, e.g. emulsions, dispersions, microcapsules
    • A61K51/1282—Devices used in vivo and carrying the radioactive therapeutic or diagnostic agent, therapeutic or in vivo diagnostic kits, stents
    • G—PHYSICS
    • G21—NUCLEAR PHYSICS; NUCLEAR ENGINEERING
    • G21G—CONVERSION OF CHEMICAL ELEMENTS; RADIOACTIVE SOURCES
    • G21G1/00—Arrangements for converting chemical elements by electromagnetic radiation, corpuscular radiation or particle bombardment, e.g. producing radioactive isotopes
    • G21G1/0005—Isotope delivery systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N5/00—Radiation therapy
    • A61N5/10—X-ray therapy; Gamma-ray therapy; Particle-irradiation therapy
    • A61N5/1001—X-ray therapy; Gamma-ray therapy; Particle-irradiation therapy using radiation sources introduced into or applied onto the body; brachytherapy
    • A61N2005/1019—Sources therefor
    • A61N2005/1024—Seeds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N5/00—Radiation therapy
    • A61N5/10—X-ray therapy; Gamma-ray therapy; Particle-irradiation therapy
    • A61N5/1048—Monitoring, verifying, controlling systems and methods
    • A61N5/1049—Monitoring, verifying, controlling systems and methods for verifying the position of the patient with respect to the radiation beam
    • A61N2005/105—Monitoring, verifying, controlling systems and methods for verifying the position of the patient with respect to the radiation beam using a laser alignment system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N5/00—Radiation therapy
    • A61N5/10—X-ray therapy; Gamma-ray therapy; Particle-irradiation therapy
    • A61N2005/1085—X-ray therapy; Gamma-ray therapy; Particle-irradiation therapy characterised by the type of particles applied to the patient

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Physics & Mathematics (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Optics & Photonics (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Biomedical Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • High Energy & Nuclear Physics (AREA)
  • General Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Dispersion Chemistry (AREA)
  • Radiology & Medical Imaging (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pathology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Inorganic Chemistry (AREA)
  • Radiation-Therapy Devices (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

Un método para acumular radionucleidos de radio, que comprende proporcionar una primera solución que incluye radionucleidos de torio y un extractante de unión a torio, en donde la primera solución no se une al radio, lo que permite que una porción de los radionucleidos de torio en la primera solución se descomponga en átomos de radio y recolectar los átomos de radio resultantes de la descomposición. Los átomos de radio recolectados pueden incluirse en una solución en la que se sumergen las fuentes de braquiterapia, de manera que los átomos de radio se recolectan en la fuente.
MX2022002753A 2019-10-10 2020-10-05 Preparacion humeda de fuentes de radioterapia. MX2022002753A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201962913184P 2019-10-10 2019-10-10
PCT/IB2020/059317 WO2021070029A1 (en) 2019-10-10 2020-10-05 Wet preparation of radiotherapy sources

Publications (1)

Publication Number Publication Date
MX2022002753A true MX2022002753A (es) 2022-04-06

Family

ID=75437140

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2022002753A MX2022002753A (es) 2019-10-10 2020-10-05 Preparacion humeda de fuentes de radioterapia.

Country Status (9)

Country Link
US (1) US20210128945A1 (es)
EP (1) EP4041386A4 (es)
JP (2) JP7372706B2 (es)
KR (1) KR20220076473A (es)
CN (1) CN114502238A (es)
AU (4) AU2020362983B2 (es)
CA (1) CA3152075A1 (es)
MX (1) MX2022002753A (es)
WO (1) WO2021070029A1 (es)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9821174B1 (en) 2015-02-06 2017-11-21 Gammatile Llc Radioactive implant planning system and placement guide system
US10888710B1 (en) 2016-11-29 2021-01-12 Gt Medical Technologies, Inc. Transparent loading apparatus
US11317321B1 (en) 2020-10-27 2022-04-26 Sprint Communications Company L.P. Methods for delivering network slices to a user
WO2023161840A1 (en) * 2022-02-24 2023-08-31 Alpha Tau Medical Ltd. Convection-enhanced diffusing alpha-emitter radiation therapy
CN117695844A (zh) * 2024-02-05 2024-03-15 北京先通国际医药科技股份有限公司 一种提取钍元素的衰变子体的方法

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1644049B1 (en) 2003-04-30 2007-09-26 Ramot at Tel Aviv University Ltd. Method and device for radiotherapy
US8323172B2 (en) * 2008-05-02 2012-12-04 Civatech Oncology Brachytherapy devices and related methods and computer program products
RU2513206C1 (ru) * 2012-10-30 2014-04-20 Леонид Асхатович Мазитов Способ разделения тория-228 и радия-224
US9951399B2 (en) 2014-04-09 2018-04-24 Los Alamos National Security, Llc Separation of protactinum, actinium, and other radionuclides from proton irradiated thorium target
EP3762103A4 (en) 2018-03-08 2021-12-01 Alpha TAU Medical Ltd. RADIATION THERAPY SEEDS AND APPLICATORS
EP3773996A4 (en) * 2018-03-26 2022-03-30 Triumf SYSTEMS, DEVICE AND METHOD FOR THE SEPARATION OF ACTINIUM, RADIUM AND THORIUM

Also Published As

Publication number Publication date
JP7372706B2 (ja) 2023-11-01
EP4041386A1 (en) 2022-08-17
JP2023176012A (ja) 2023-12-12
AU2020362983B2 (en) 2023-05-25
KR20220076473A (ko) 2022-06-08
JP2022553484A (ja) 2022-12-23
AU2020362983A1 (en) 2022-03-31
AU2023203994A1 (en) 2023-07-13
WO2021070029A1 (en) 2021-04-15
EP4041386A4 (en) 2023-11-22
AU2023203997A1 (en) 2023-07-13
CA3152075A1 (en) 2021-04-15
CN114502238A (zh) 2022-05-13
AU2023203996A1 (en) 2023-07-13
US20210128945A1 (en) 2021-05-06

Similar Documents

Publication Publication Date Title
MX2022002753A (es) Preparacion humeda de fuentes de radioterapia.
Aaboud et al. Electron efficiency measurements with the ATLAS detector using 2012 LHC proton–proton collision data
Aad et al. Search for pair and single production of new heavy quarks that decay to a Z boson and a third-generation quark in pp collisions at $$\sqrt {s}= 8$$ TeV with the ATLAS detector
Aad et al. Search for pair-produced long-lived neutral particles decaying to jets in the ATLAS hadronic calorimeter in pp collisions at s= 8TeV
MX2020009940A (es) Liberacion controlada de radionucleidos.
Aad et al. Search for the Standard Model Higgs boson in the H→ WW (⋆)→ ℓνℓν decay mode with 4.7 fb− 1 of ATLAS data at s= 7 TeV
Aad et al. Search for pair production of heavy top-like quarks decaying to a high-pT W boson and ab quark in the lepton plus jets final state at s= 7TeV with the ATLAS detector
Lennarz et al. In-trap spectroscopy of charge-bred radioactive ions
Aad et al. Search for R-parity-violating supersymmetry in events with four or more leptons in $\sqrt {s}= 7\;\mathrm {TeV} $ pp collisions with the ATLAS detector
CY1120981T1 (el) Πηγη ραδιενεργης επιφανειας και μεθοδος για την παραγωγη της
RU2569543C1 (ru) Способ получения радионуклида никель-63 для бета-вольтаических источников тока
EP4038639A4 (en) INTEGRATED NEUTRON SHIELDING IN A CONTAINER
IL278795A (en) Microspheres containing radioactive isotopes and other markers and related methods
JP6802902B2 (ja) ニッケル−６３放射性核種の製造方法
IL289040A (en) Antibodies that bind to cancer cells and direct radionuclides to these cells
Langer et al. The Radioactivity of Ga 66
肖燕飞 et al. Investigation of natural radionuclide distribution in rare earth extraction process from ion-adsorption type rare earths ore
FR1211044A (fr) Perfectionnements apportés aux implants intra-osseux, outillages permettant leur implantation et leurs applications
Benesty et al. JININ
Gorman et al. Alpha Decay of Am 240
Dyer et al. The decay of 58Mn
Sukhoruchkin et al. Neutron Resonance Parameters for Bi-209 (Bismuth) 83-Bismuth
Sukhoruchkin et al. Neutron Resonance Parameters for Sn-115 (Tin) 50-Tin
Shamal et al. Application microbiological preparation EM-1 and mineral sorbent for growing plants on the soils contaminated by radionuclides
Sukhoruchkin et al. Neutron Resonance Parameters for Hg-196 (Mercury) 80-Mercury